It became clear by the start of the fourth quarter that the overblown fairytale calling for a recession in 2019 had all but vanished. Additionally, the Fed made life easier too, clearly signaling it ...
Nektar Therapeutics (NASDAQ: NKTR) is at the top of the list. Also on the list is Anadarko Petroleum (NYSE: APC). The list also includes Alexion Pharmaceuticals (NASDAQ: ALXN). We’re heading into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback